Successful Certolizumab Pegol Treatment of Chronic Anterior Uveitis Associated with Psoriasis Vulgaris

This report presents details on a 45-year-old male Japanese patient with chronic and refractory anterior uveitis associated with psoriasis vulgaris who was administered certolizumab pegol (CZP), which is an anti-tumor necrosis factor alpha (TNF-α) monoclonal antibody. Although CZP has only been form...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Keiko, Hayashi, Takaaki, Takahashi, Genichiro, Momose, Mami, Asahina, Akihiko, Nakano, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341314/
https://www.ncbi.nlm.nih.gov/pubmed/30687070
http://dx.doi.org/10.1159/000495655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341314/
https://www.ncbi.nlm.nih.gov/pubmed/30687070
http://dx.doi.org/10.1159/000495655

Ejemplares similares